Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Shares of Danish biotech Bavarian Nordic surged on Thursday after the company reported strong earnings and a large order of its mpox vaccine, extending its gains this year as nations mobilize to combat an escalating outbreak of the disease in Africa.reported
It grows Bavarian’s year-to-date gains to more than 55%, almost all of which has happened in the last month.a 440,000 dose contract with an undisclosed European country for its mpox vaccine, the only shot authorized for use against the virus in both the U.S. and the European Union, which it said will be delivered this year.
Monkeypox Bavarian Nordic Shares Stock Outbreak WHO Clade Vaccine
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mpox Vaccine Maker’s Shares Continue Rising As Concern Over Virus Outbreak GrowsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU approval for teens after WHO declares health emergencyCEO Paul Chaplin told CNBC that the expanded approval for 12 to 17 year-olds would be crucial in tackling the latest outbreak.
Read more »
Mpox Vaccine Maker’s Shares Continue Rising As Concern Over Virus Outbreak GrowsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Vaccine Maker Shares Soar After WHO Declares Health Emergency Over Africa Mpox OutbreakRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Vaccine Maker Shares Soar After WHO Declares Health Emergency Over Africa Mpox OutbreakRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Bavarian Nordic shares pop over 13% on earnings beat, bumper mpox vaccine orderShares of Danish biotech company Bavarian Nordic jumped Thursday after reporting first-half earnings and a bumper mpox vaccine order.
Read more »